These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 23575412

  • 1. Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.
    Kogure Y, Ando M, Saka H, Chiba Y, Yamamoto N, Asami K, Hirashima T, Seto T, Nagase S, Otsuka K, Yanagihara K, Takeda K, Okamoto I, Aoki T, Takayama K, Yamasaki M, Kudoh S, Katakami N, Miyazaki M, Nakagawa K.
    J Thorac Oncol; 2013 Jun; 8(6):753-8. PubMed ID: 23575412
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T, Takada M, Kubo A, Matsumura A, Fukai S, Tamura A, Saito R, Maruyama Y, Kawahara M, Ignatius Ou SH.
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer.
    Besse B, Planchard D, Veillard AS, Taillade L, Khayat D, Ducourtieux M, Pignon JP, Lumbroso J, Lafontaine C, Mathiot C, Soria JC.
    Lung Cancer; 2012 Apr; 76(1):78-83. PubMed ID: 22186627
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.
    Aarts MJ, van den Borne BE, Biesma B, Kloover JS, Aerts JG, Lemmens VE.
    Int J Cancer; 2015 Mar 01; 136(5):E387-95. PubMed ID: 25219898
    [Abstract] [Full Text] [Related]

  • 11. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C, Dong W, Su B, Liu Q, Du J.
    J Thorac Oncol; 2013 Apr 01; 8(4):429-35. PubMed ID: 23486264
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
    Saji H, Tsuboi M, Yoshida K, Kato Y, Nomura M, Matsubayashi J, Nagao T, Kakihana M, Usuda J, Kajiwara N, Ohira T, Ikeda N.
    J Thorac Oncol; 2011 Nov 01; 6(11):1865-71. PubMed ID: 21964529
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.
    Chhajed PN, Baty F, Pless M, Somandin S, Tamm M, Brutsche MH.
    Chest; 2006 Dec 01; 130(6):1803-7. PubMed ID: 17167000
    [Abstract] [Full Text] [Related]

  • 18. Retrospective analysis of third-line chemotherapy in advanced non-small cell lung cancer.
    Tatli AM, Arslan D, Uysal M, Goksu SS, Gunduz SG, Coskun HS, Ozdogan M, Savas B, Bozcuk HS.
    J Cancer Res Ther; 2015 Dec 01; 11(4):805-9. PubMed ID: 26881522
    [Abstract] [Full Text] [Related]

  • 19. Retrospective analysis of third-line and fourth-line chemotherapy for advanced non-small-cell lung cancer.
    Asahina H, Sekine I, Horinouchi H, Nokihara H, Yamamoto N, Kubota K, Tamura T.
    Clin Lung Cancer; 2012 Jan 01; 13(1):39-43. PubMed ID: 21890422
    [Abstract] [Full Text] [Related]

  • 20. A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancer.
    Rodrigues-Pereira J, Kim JH, Magallanes M, Lee DH, Wang J, Ganju V, Martínez-Barrera L, Barraclough H, van Kooten M, Orlando M.
    J Thorac Oncol; 2011 Nov 01; 6(11):1907-14. PubMed ID: 22005471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.